Refractory Acute Lymphocytic Leukemia
Showing 1 - 25 of >10,000
Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)
Recruiting
- Non-hodgkin Lymphoma
- +2 more
- CC312
-
Tianjin, Tianjin, ChinaInstituteHBDH
Sep 12, 2023
Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +15 more
- Anti-CD19/CD20/CD22 CAR T-Cells
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 4, 2022
Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T
Recruiting
- Non Hodgkin Lymphoma
- +2 more
- Fully human anti CD19 CAR-T Cell Dose
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Oct 4, 2022
T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)
Recruiting
- T-Cell Acute Lymphocytic Leukemia
- CD7 CAR-T
-
Langfang, Hebei, ChinaHebei Yanda Hospital
Jun 26, 2023
Relapsed Childhood ALL, Relapsed Childhood Lymphoblastic Lymphoma Trial in Dallas (Venetoclax, Navitoclax)
Available
- Relapsed Childhood ALL
- Relapsed Childhood Lymphoblastic Lymphoma
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Feb 28, 2022
ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)
Not yet recruiting
- ALL, Childhood B-Cell
- +2 more
- Tafasitamab
- (no location specified)
Nov 25, 2022
Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Refractory, B-cell Lymphoma Recurrent Trial in São Paulo
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +5 more
- Cyclophosphamide
- +2 more
-
São Paulo, BrazilHospital Israelita Albert Einstein
Jan 20, 2023
Acute Lymphocytic Leukemia Trial in Beijing, Tianjin (LCAR-AIO Cells)
Recruiting
- Acute Lymphocytic Leukemia
- LCAR-AIO Cells
-
Beijing, Beijing, China
- +1 more
May 31, 2022
Acute Lymphocytic Leukemia Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor (CAR) T Cells)
Recruiting
- Acute Lymphocytic Leukemia
- CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
-
Tianjin, Tianjin, ChinaHematology Hospital, Chinese Academy of Medical Sciences
Feb 5, 2023
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,
Not yet recruiting
- Acute Myelogenous Leukemia
- +17 more
- Peripheral Blood Stem Cell Transplant
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Mar 27, 2023
B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, Unspecified Trial in Guangzhou, Guanzhou (CD19 CAR T-Cell(CAT19T2))
Not yet recruiting
- B-cell Acute Lymphoblastic Leukemia
- B-Cell Lymphoma, Unspecified
- CD19 CAR T-Cell(CAT19T2)
-
Guangzhou, Guangdong, China
- +1 more
Nov 4, 2022
Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +5 more
- CD19 specific Chimeric Antigen Receptor T Cell
-
Columbus, OhioNationwide Children's Hospital
Mar 9, 2023
Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- allogenic CD19-CAR-NK cells
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Feb 11, 2023
Lymphoma Leukemia Trial in Minneapolis (allogeneic CAR19 regulatory T cells (CAR19-tTreg))
Not yet recruiting
- Lymphoma Leukemia
- allogeneic CAR19 regulatory T cells (CAR19-tTreg)
- +2 more
-
Minneapolis, MinnesotaMasonic Cancer Center - University of Minnesota
Dec 6, 2022
Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Beijing (CAR-NK-CD19 Cells)
Recruiting
- Acute Lymphocytic Leukemia
- +2 more
- CAR-NK-CD19 Cells
-
Beijing, Beijing, ChinaBeijing Boren Hospital
Jun 5, 2022
Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati
Recruiting
- Relapsed/Refractory Leukemias
- +4 more
- SNDX-5613
- +2 more
-
Kansas City, Missouri
- +1 more
Jul 18, 2022
B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,
Active, not recruiting
- B-Lymphoid Malignancies
- +3 more
- Fludarabine
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 1, 2022
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia Trial in Fairway (Daunorubicin)
Completed
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia
-
Fairway, KansasUniversity of Kansas Cancer Center - Clinical Research Center
Jan 12, 2022
Leukemia, Acute Lymphocytic Trial in Durham (Copanlisib)
Recruiting
- Leukemia, Acute Lymphocytic
-
Durham, North CarolinaDuke Cancer Center
Jun 28, 2022
Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)
Not yet recruiting
- Acute Lymphoid Leukemia
- +4 more
- fludarabine
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
B-Cell Leukemia, B Cell Lymphoma Trial in Kunming (anti-CD19 UCAR-T injection)
Recruiting
- B-Cell Leukemia
- B Cell Lymphoma
- anti-CD19 UCAR-T injection
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Apr 21, 2022
Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,
Recruiting
- Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
-
Duarte, California
- +12 more
Jan 4, 2023
Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow
Recruiting
- Acute Myeloid Leukemia
- +3 more
- Fludarabine + Total Marrow Irradiation
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jun 1, 2022
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)
Recruiting
- Acute Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 26, 2022
Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in Vancouver, Ottawa (CLIC-1901)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- CLIC-1901
-
Vancouver, British Columbia, Canada
- +1 more
Mar 26, 2022